Abbott Laboratories (ABT)
115.03
-0.71
(-0.61%)
USD |
NYSE |
Nov 14, 16:00
115.06
+0.02
(+0.02%)
Pre-Market: 20:00
Abbott Laboratories Free Cash Flow (Quarterly): 2.149B for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.149B |
| June 30, 2024 | 1.427B |
| March 31, 2024 | 627.00M |
| December 31, 2023 | 2.283B |
| September 30, 2023 | 1.317B |
| June 30, 2023 | 696.00M |
| March 31, 2023 | 763.00M |
| December 31, 2022 | 1.716B |
| September 30, 2022 | 2.313B |
| June 30, 2022 | 2.031B |
| March 31, 2022 | 1.744B |
| December 31, 2021 | 2.453B |
| September 30, 2021 | 2.24B |
| June 30, 2021 | 1.715B |
| March 31, 2021 | 2.24B |
| December 31, 2020 | 3.119B |
| September 30, 2020 | 1.57B |
| June 30, 2020 | 680.00M |
| March 31, 2020 | 355.00M |
| December 31, 2019 | 1.982B |
| September 30, 2019 | 1.547B |
| June 30, 2019 | 592.00M |
| March 31, 2019 | 377.00M |
| December 31, 2018 | 1.298B |
| September 30, 2018 | 1.829B |
| Date | Value |
|---|---|
| June 30, 2018 | 946.00M |
| March 31, 2018 | 833.00M |
| December 31, 2017 | 1.295B |
| September 30, 2017 | 1.742B |
| June 30, 2017 | 1.096B |
| March 31, 2017 | 302.00M |
| December 31, 2016 | 851.00M |
| September 30, 2016 | 905.00M |
| June 30, 2016 | 662.00M |
| March 31, 2016 | -336.00M |
| December 31, 2015 | 580.00M |
| September 30, 2015 | 784.00M |
| June 30, 2015 | 725.00M |
| March 31, 2015 | -233.00M |
| December 31, 2014 | 951.00M |
| September 30, 2014 | 924.00M |
| June 30, 2014 | 642.00M |
| March 31, 2014 | 81.00M |
| December 31, 2013 | 1.322B |
| September 30, 2013 | 245.00M |
| June 30, 2013 | 426.00M |
| March 31, 2013 | 186.00M |
| December 31, 2012 | 1.117B |
| September 30, 2012 | 2.989B |
| June 30, 2012 | 1.642B |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
355.00M
Minimum
Mar 2020
3.119B
Maximum
Dec 2020
1.671B
Average
1.73B
Median
Free Cash Flow (Quarterly) Benchmarks
| Boston Scientific Corp | 698.00M |
| Becton Dickinson & Co | 883.00M |
| ResMed Inc | 305.93M |
| Globus Medical Inc | 161.70M |
| Insulet Corp | 69.40M |